Top Markets
#1 Derive Derive +32.37%
#2 Cross Cross +15.42%
#3 Glidr Glidr +10.10%
#4 Gama Token Gama Token +9.10%
#5 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +6.92%
#6 Palladium Network Palladium Network +6.09%
#7 Based Based +5.99%
#8 Geodnet Geodnet +5.11%
#9 龙虾 (Lobster) 龙虾 (Lobster) +5.09%
#10 Talus Network Talus Network +4.83%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Rank in Stocks #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Share Price
$0.94
Last synced: 2025-02-28
Market Cap
$2.73M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Fresh Tracks Therapeutics, Inc. (FRTX)

Category

Healthcare
Number of shares outstanding for Fresh Tracks Therapeutics, Inc. (FRTX)
Number of shares outstanding as of December 2023: 5.91M
According to Fresh Tracks Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 5.91M. At the end of December 2022 the company had 2.81M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Fresh Tracks Therapeutics, Inc. (FRTX) from 2000 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 5.91M 0.00%
2023 5.91M 110.56%
2022 2.81M 57.33%
2021 1.78M 227.63%
2020 544.76K 710.92%
2019 67.18K -3.12%
2018 69.34K 69.47%
2017 40.91K 28.64%
2016 31.81K 9.20%
2015 29.13K 3.33%
2014 28.19K 2.24%
2013 27.57K 1.02%
2012 27.29K 19.35%
2011 22.87K 19.88%
2010 19.07K 27.61%
2009 14.95K 18.14%
2008 12.65K 1.70%
2007 12.44K 24.67%
2006 9.98K 27.89%
2005 7.80K 8.31%
2004 7.20K 12.95%
2003 6.38K 0.06%
2002 6.37K 0.24%
2001 6.36K 1.74%
2000 6.25K 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 4,194.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 951.71%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE